Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EVOLOCUMAB vs EZETIMIBE\ROSUVASTATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EVOLOCUMAB vs EZETIMIBE\ROSUVASTATIN: Safety Overview

Metric EVOLOCUMAB EZETIMIBE\ROSUVASTATIN
Total FAERS Reports 149,666 329
Deaths Reported 1,723 14
Death Rate 1.2% 4.3%
Hospitalizations 6,890 138
Average Patient Age 68.1 yrs 65.8 yrs
% Female Patients 58.8% 26.8%
Manufacturer Amgen USA Inc. N/A
Route SUBCUTANEOUS N/A
Marketing Status Prescription N/A